Intuitive Surgical (IUI1) Stock Forecast & Price Target

Compare

33 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

IUI1 Analyst Ratings

Strong Buy

14 Buy

4 Hold

0 Sell

Based on 18 analysts giving stock ratings to

Intuitive

Surgical

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

IUI1 Stock 12 Month Forecast

Average Price Target

€561.89

▲(33.88% Upside)

Based on 18 Wall Street analysts offering 12 month price targets for Intuitive Surgical in the last 3 months. The average price target is €561.89 with a high forecast of €652.62 and a low forecast of €478.59. The average price target represents a 33.88% change from the last price of €419.70.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"368":"€368","653":"€653","439.25":"€439.3","510.5":"€510.5","581.75":"€581.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":652.6199625,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€652.62</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":561.8912850466667,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€561.89</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":478.58797250000003,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€478.59</span>\n  </div></div>","useHTML":true}}],"tickPositions":[368,439.25,510.5,581.75,653],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,423.4,441.0323048076923,458.6646096153846,476.29691442307694,493.92921923076926,511.5615240384616,529.1938288461539,546.8261336538462,564.4584384615384,582.0907432692309,599.7230480769231,617.3553528846154,634.9876576923077,{"y":652.6199625,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,423.4,434.0531757728205,444.706351545641,455.3595273184615,466.01270309128205,476.6658788641025,487.31905463692306,497.9722304097436,508.6254061825641,519.2785819553847,529.9317577282052,540.5849335010256,551.2381092738461,{"y":561.8912850466667,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,423.4,427.6452286538461,431.8904573076923,436.13568596153846,440.3809146153846,444.6261432692308,448.87137192307694,453.1166005769231,457.3618292307692,461.6070578846154,465.85228653846156,470.0975151923077,474.3427438461539,{"y":478.58797250000003,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":538.7,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 43,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":457.25,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":449.3,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":480.9,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":455.75,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":417.8,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":405,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":369.85,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":462.35,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":491,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":489.2,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":423.8,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":423.4,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€652.62

Average Price Target€561.89

Lowest Price Target€478.59

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Danielle Antalffy

UBS

€495.99→€478.59

Hold

14.03%

Upside

Assigned

03/17/26

Intuitive Surgical price target lowered to $550 from $570 at UBSIntuitive Surgical price target lowered to $550 from $570 at UBS

Joanne Wuensch

Citi

€513.39

Buy

22.32%

Upside

Upgraded

03/12/26

Intuitive Surgical upgraded to Buy from Neutral at CitiIntuitive Surgical upgraded to Buy from Neutral at Citi

Shagun Singh Chadha

RBC Capital

€565.6

Buy

34.76%

Upside

Reiterated

02/24/26

RBC Capital Sticks to Its Buy Rating for Intuitive Surgical (ISRG)

Ryan Zimmerman

BTIG

€536.02

Buy

27.71%

Upside

Reiterated

02/18/26

BTIG Keeps Their Buy Rating on Intuitive Surgical (ISRG)

Travis Steed

Bank of America Securities

€565.6

Buy

34.76%

Upside

Reiterated

02/13/26

Bank of America Securities Sticks to Their Buy Rating for Intuitive Surgical (ISRG)

Mathew Blackman

TD Cowen

€574.31

Buy

36.84%

Upside

Reiterated

02/09/26

Analysts Offer Insights on Healthcare Companies: Roche Holding (Other OTC: RHHBY) and Intuitive Surgical (NASDAQ: ISRG)

Brandon Vazquez

William Blair

―

Buy

―

Reiterated

02/05/26

Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (NASDAQ: ISRG) and Daiichi Sankyo Company (Other OTC: DSKYF)

Adam Maeder

Piper Sandler

€539.5

Buy

28.54%

Upside

Reiterated

02/02/26

Analysts Offer Insights on Healthcare Companies: AbbVie (NYSE: ABBV), Intuitive Surgical (NASDAQ: ISRG) and Thermo Fisher (NYSE: TMO)

Patrick Wood

Morgan Stanley

€565.6

Buy

34.76%

Upside

Reiterated

01/28/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Bristol-Myers Squibb (NYSE: BMY), HCA Healthcare (NYSE: HCA) and Intuitive Surgical (NASDAQ: ISRG)

Suraj Kalia

Oppenheimer

―

Hold

―

Reiterated

01/23/26

Analysts Conflicted on These Healthcare Names: Intuitive Surgical (NASDAQ: ISRG) and Abbott Laboratories (NYSE: ABT)

Richard Newitter

Truist Financial

€565.6

Buy

34.76%

Upside

Reiterated

01/23/26

Intuitive Surgical (ISRG) Gets a Buy from Truist Financial

Anthony Petrone

Mizuho Securities

―

Hold

―

Reiterated

01/23/26

Analysts Offer Insights on Healthcare Companies: COMPASS Pathways (NASDAQ: CMPS), Intuitive Surgical (NASDAQ: ISRG) and Sanofi (Other OTC: SNYNF)

Matt Miksic

Barclays

€596.93→€619.55

Buy

47.62%

Upside

Reiterated

01/23/26

Barclays Remains a Buy on Intuitive Surgical (ISRG)

Larry Biegelsen

Wells Fargo

€522.1→€569.08

Buy

35.59%

Upside

Reiterated

01/23/26

Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (NASDAQ: ISRG), OnKure Therapeutics (NASDAQ: OKUR) and Praxis Precision Medicines (NASDAQ: PRAX)

Vijay Kumar

Evercore ISI

€504.69→€478.59

Hold

14.03%

Upside

Reiterated

01/23/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Corcept Therapeutics (NASDAQ: CORT), Intuitive Surgical (NASDAQ: ISRG) and Vertex Pharmaceuticals (NASDAQ: VRTX)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Danielle Antalffy

UBS

€495.99→€478.59

Hold

14.03%

Upside

Assigned

03/17/26

Intuitive Surgical price target lowered to $550 from $570 at UBSIntuitive Surgical price target lowered to $550 from $570 at UBS

Joanne Wuensch

Citi

€513.39

Buy

22.32%

Upside

Upgraded

03/12/26

Intuitive Surgical upgraded to Buy from Neutral at CitiIntuitive Surgical upgraded to Buy from Neutral at Citi

Shagun Singh Chadha

RBC Capital

€565.6

Buy

34.76%

Upside

Reiterated

02/24/26

RBC Capital Sticks to Its Buy Rating for Intuitive Surgical (ISRG)

Ryan Zimmerman

BTIG

€536.02

Buy

27.71%

Upside

Reiterated

02/18/26

BTIG Keeps Their Buy Rating on Intuitive Surgical (ISRG)

Travis Steed

Bank of America Securities

€565.6

Buy

34.76%

Upside

Reiterated

02/13/26

Bank of America Securities Sticks to Their Buy Rating for Intuitive Surgical (ISRG)

Mathew Blackman

TD Cowen

€574.31

Buy

36.84%

Upside

Reiterated

02/09/26

Analysts Offer Insights on Healthcare Companies: Roche Holding (Other OTC: RHHBY) and Intuitive Surgical (NASDAQ: ISRG)

Brandon Vazquez

William Blair

―

Buy

―

Reiterated

02/05/26

Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (NASDAQ: ISRG) and Daiichi Sankyo Company (Other OTC: DSKYF)

Adam Maeder

Piper Sandler

€539.5

Buy

28.54%

Upside

Reiterated

02/02/26

Analysts Offer Insights on Healthcare Companies: AbbVie (NYSE: ABBV), Intuitive Surgical (NASDAQ: ISRG) and Thermo Fisher (NYSE: TMO)

Patrick Wood

Morgan Stanley

€565.6

Buy

34.76%

Upside

Reiterated

01/28/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Bristol-Myers Squibb (NYSE: BMY), HCA Healthcare (NYSE: HCA) and Intuitive Surgical (NASDAQ: ISRG)

Suraj Kalia

Oppenheimer

―

Hold

―

Reiterated

01/23/26

Analysts Conflicted on These Healthcare Names: Intuitive Surgical (NASDAQ: ISRG) and Abbott Laboratories (NYSE: ABT)

Richard Newitter

Truist Financial

€565.6

Buy

34.76%

Upside

Reiterated

01/23/26

Intuitive Surgical (ISRG) Gets a Buy from Truist Financial

Anthony Petrone

Mizuho Securities

―

Hold

―

Reiterated

01/23/26

Analysts Offer Insights on Healthcare Companies: COMPASS Pathways (NASDAQ: CMPS), Intuitive Surgical (NASDAQ: ISRG) and Sanofi (Other OTC: SNYNF)

Matt Miksic

Barclays

€596.93→€619.55

Buy

47.62%

Upside

Reiterated

01/23/26

Barclays Remains a Buy on Intuitive Surgical (ISRG)

Larry Biegelsen

Wells Fargo

€522.1→€569.08

Buy

35.59%

Upside

Reiterated

01/23/26

Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (NASDAQ: ISRG), OnKure Therapeutics (NASDAQ: OKUR) and Praxis Precision Medicines (NASDAQ: PRAX)

Vijay Kumar

Evercore ISI

€504.69→€478.59

Hold

14.03%

Upside

Reiterated

01/23/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Corcept Therapeutics (NASDAQ: CORT), Intuitive Surgical (NASDAQ: ISRG) and Vertex Pharmaceuticals (NASDAQ: VRTX)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Intuitive Surgical

3 Months

xxx

Success Rate

22/29 ratings generated profit

Average Return

+7.82%

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 75.86% of your transactions generating a profit, with an average return of +7.82% per trade.

1 Year

Joanne WuenschCiti

Success Rate

19/23 ratings generated profit

Average Return

+25.18%

Copying Joanne Wuensch's trades and holding each position for 1 Year would result in 82.61% of your transactions generating a profit, with an average return of +25.18% per trade.

2 Years

xxx

Success Rate

21/23 ratings generated profit

Average Return

+46.85%

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 91.30% of your transactions generating a profit, with an average return of +46.85% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

IUI1 Analyst Recommendation Trends

Rating

Nov 25

Dec 25

Jan 26

Feb 26

Mar 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, IUI1 has received 27 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. IUI1 average Analyst price target in the past 3 months is 561.89.

Each month's total comprises the sum of three months' worth of ratings.

IUI1 Financial Forecast

IUI1 Earnings Forecast

Next quarter’s earnings estimate for IUI1 is €1.85 with a range of €1.77 to €2.20. The previous quarter’s EPS was €2.20. IUI1 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year IUI1 has Performed in-line its overall industry.

IUI1 Sales Forecast

Next quarter’s sales forecast for IUI1 is €2.28B with a range of €2.23B to €2.37B. The previous quarter’s sales results were €2.49B. IUI1 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year IUI1 has Performed in-line its overall industry.

IUI1 Stock Forecast FAQ

What is DE:IUI1’s average 12-month price target, according to analysts?

Based on analyst ratings, Intuitive Surgical’s 12-month average price target is 561.89.

What is DE:IUI1’s upside potential, based on the analysts’ average price target?

Intuitive Surgical has 33.88% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Intuitive Surgical a Buy, Sell or Hold?

Intuitive Surgical has a consensus rating of Strong Buy, which is based on 14 buy ratings, 4 hold ratings and 0 sell ratings.

What is Intuitive Surgical’s share price target?

The average share price target for Intuitive Surgical is 561.89. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €652.62 ,and the lowest forecast is €478.59. The average share price target represents 33.88% Increase from the current price of €419.7.

What do analysts say about Intuitive Surgical?

Intuitive Surgical’s analyst rating consensus is a Strong Buy. This is based on the ratings of 18 Wall Streets Analysts.

How can I buy shares of Intuitive Surgical?

To buy shares of DE:IUI1, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Intuitive Surgical (IUI1) Stock Forecast & Price Target

IUI1 Analyst Ratings

IUI1 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Intuitive Surgical

IUI1 Analyst Recommendation Trends

IUI1 Financial Forecast

IUI1 Earnings Forecast

IUI1 Sales Forecast

IUI1 Stock Forecast FAQ

Detailed List of Analyst Forecasts